We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-19.38%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$398M
AUM Growth
-$344M
Cap. Flow
-$86.1M
Cap. Flow %
-21.65%
Top 10 Hldgs %
44.07%
Holding
188
New
36
Increased
27
Reduced
23
Closed
84

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$14.6M
2
CELG
Celgene Corp
CELG
+$10.8M
3
TLND
Talend S.A. American Depositary Shares
TLND
+$9.74M
4
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$9.08M
5
ZEN
ZENDESK INC
ZEN
+$8.55M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$27M
2
KNX icon
Knight Transportation
KNX
+$17.2M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$15.8M
4
MGY icon
Magnolia Oil & Gas
MGY
+$14.6M
5
ADMS
Adamas Pharmaceuticals
ADMS
+$10.2M

Sector Composition

Rank Sector Weight
1 Technology 32.57%
2 Healthcare 22.29%
3 Industrials 11.87%
4 Utilities 10.14%
5 Miscellaneous 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STZ icon
151
Constellation Brands
STZ
$20.9B
– –
-2,000
Closed -$432K
TLRY icon
152
PUT
Tilray
TLRY
$553M
– –
-1,500
Closed -$2.15M
TSLA icon
153
Tesla
TSLA
$1.44T
– –
-37,500
Closed -$661K
TSLA icon
154
PUT
Tesla
TSLA
$1.44T
– –
-75,000
Closed -$1.32M
TSN icon
155
Tyson Foods
TSN
$18.6B
– –
-5,000
Closed -$298K
TWLO icon
156
Twilio
TWLO
$34.9B
– –
-4,000
Closed -$346K
TXMD icon
157
TherapeuticsMD
TXMD
$25M
– –
-15,000
Closed -$4.92M
VATE icon
158
INNOVATE Corp
VATE
$97.7M
– –
-48,650
Closed -$2.98M
VKTX icon
159
Viking Therapeutics
VKTX
$3.73B
– –
-10,000
Closed -$174K
WPRT
160
Westport Fuel Systems
WPRT
$35M
– –
-40,000
Closed -$1.2M
ZBH icon
161
Zimmer Biomet
ZBH
$17.8B
– –
-7,725
Closed -$986K
RNTX
162
Rein Therapeutics
RNTX
$67.7M
– –
-1,500
Closed -$83K
ENZ
163
DELISTED
Enzo Biochem, Inc.
ENZ
– –
-10,000
Closed -$41K
ITI
164
DELISTED
Iteris, Inc.
ITI
– –
-460,000
Closed -$2.48M
PETQ
165
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
-10,000
Closed -$393K
SPWR
166
DELISTED
SunPower Corporation Common Stock
SPWR
– –
-38,175
Closed -$183K
EIGR
167
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-833
Closed -$300K
SPLK
168
DELISTED
Splunk Inc
SPLK
– –
-5,000
Closed -$605K
VMW
169
DELISTED
VMware, Inc
VMW
– –
-7,000
Closed -$1.09M
NEWR
170
DELISTED
New Relic, Inc.
NEWR
– –
-7,000
Closed -$660K
SYNH
171
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-15,000
Closed -$773K
AGFS
172
DELISTED
AgroFresh Solutions Inc
AGFS
– –
-85,000
Closed -$530K
TMX
173
DELISTED
Terminix Global Holdings, Inc.
TMX
– –
-7,465
Closed -$310K
TYME
174
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
– –
-902,500
Closed -$2.51M
MNDT
175
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-10,000
Closed -$170K
4 5 6
7
8

Similar funds

RAM
Ramirez Asset Management New York $960M AUM 30.25% 1-Year Est. Return
JWBC
J.W. Burns & Co Dewitt, New York $959M AUM 25.08% 1-Year Est. Return
PL
Parthenon LLC Louisville, Kentucky $962M AUM 27.46% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
WI
Wahed Invest New York $958M AUM 66.65% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $963M AUM 38.06% 1-Year Est. Return
ACP
Aviance Capital Partners Naples, Florida $963M AUM 32.56% 1-Year Est. Return

Ardsley Advisory Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Ardsley Advisory Partners held 188 positions worth $398M, down 46% from $742M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ardsley Advisory Partners withdrew a net $86.1M in Q4 2018, closing 84 positions and reducing 23 holdings. Its most notable exit was Marathon Petroleum, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ardsley Advisory Partners opened a new position in CVS Health worth $12.8M.

  • Ardsley Advisory Partners's largest Q4 2018 buy was CVS Health: 195,000 shares worth $12.8M.
  • Ardsley Advisory Partners added most to Celgene Corp in Q4 2018, an estimated $10.8M increase.
  • Ardsley Advisory Partners's biggest Q4 2018 reduction was Progenics Pharmaceuticals Inc, cutting an estimated $7.73M.
  • Ardsley Advisory Partners fully exited Marathon Petroleum in Q4 2018, selling an estimated $27M.
  • Ardsley Advisory Partners's ten largest holdings make up 44% of its $398M portfolio in Q4 2018.
  • Ardsley Advisory Partners opened 36 new positions and closed 84 in Q4 2018.
  • Ardsley Advisory Partners's portfolio value fell 46% quarter-over-quarter to $398M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2018, filed 14 Feb 2019.